Health CareHealth Care Equipment & Services
  • Price (EUR)27.52
  • Today's Change-0.14 / -0.51%
  • Shares traded76.55k
  • 1 Year change33.85%
  • Beta0.3842
Data delayed at least 15 minutes, as of Oct 21 2019 16:36 BST.
More ▼

Profile data is unavailable for this security.

About the company

Grandvision NV is an optical company based in the Netherlands. The Company operates directly-owned, franchise and independent retail stores providing products and services. Its products include in-house branded and third party branded prescription frames, lenses, contact lenses and sunglasses. Notable banners include Apollo-Optik in Germany; Generale d’Optique and GrandOptical in France; Pearle in the Netherlands, Belgium and Austria; Eye Wish Opticiens in the Netherlands; Vision Express in the United Kingdom, Ireland, Poland, Hungary, the Middle East and India; and Solaris internationally. Its services include eyesight examination and prescription services delivered by optometrists or opticians. The Company is geographically managed and comprises three segments: G4, which includes four European business units; Other Europe; and Latin America and Asia. The Company through approximately 40 subsidiaries in Europe, Latin America, the United States, the Middle East and Asia.

  • Revenue in EUR (TTM)3.84bn
  • Net income in EUR176.42m
  • Incorporated--
  • Employees33.72k
  • Location
    Grandvision NVThe BaseFl 6th, Evert van de Beekstraat 1-80SCHIPHOL 1118 CLNetherlandsNLD
  • Phone+31 203162636
  • Fax+31 203162630
  • Websitehttps://www.grandvision.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GVNV:AEX since
Optica 2000 SLDeal completed20 Feb 201920 Feb 2019Deal completed39.98%102.06m
Charlie Temple Europe BVAnnounced28 Jan 201928 Jan 2019Announced40.98%--
Data delayed at least 15 minutes, as of Oct 21 2019 16:36 BST.

Institutional shareholders

7.30%Per cent of shares held by top holders
HolderShares% Held
Allianz Global Investors GmbHas of 30 Jun 20193.96m1.56%
Norges Bank Investment Managementas of 31 Dec 20182.01m0.79%
Fidelity Management & Research Co.as of 31 Aug 20191.91m0.75%
T. Rowe Price International Ltd.as of 30 Sep 20191.87m0.74%
Zadig Asset Management LLPas of 30 Jun 20191.80m0.71%
Baring Asset Management Ltd.as of 30 Jun 20191.74m0.68%
Mawer Investment Management Ltd.as of 30 Jun 20191.59m0.63%
Harris Associates LPas of 30 Jun 20191.32m0.52%
The Vanguard Group, Inc.as of 30 Sep 20191.31m0.51%
Towers Watson Investment Management Ltd.as of 31 Aug 20191.07m0.42%
More ▼
Data from 31 Dec 2018 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.